Fairvalue-Calculator Fairvalue-Calculator
EN DE

Lancer Orthodontics, Inc (LANZ) Fair Value & Analysis

Healthcare · US · Market cap $42.8M

Price$0.0400
Fair Value$0.0100
Upside-75.0%
Quality89/100
Evidence: Medium Range $0.0100 – $0.0200

Fair value as of: Jun 24, 2026

Analysis

Lancer Orthodontics, Inc (LANZ) currently trades at $0.0400, while our model-based Fair Value estimate is $0.0100 — implying the stock looks roughly 75.0% overvalued today. We read business quality at 89/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Lancer Orthodontics, Inc. designs, manufactures, and markets orthodontic products for orthodontists and dentists worldwide. It offers aesthetic brackets, brackets and buccal tubes, bands, adhesives, wires, elastomerics, intraoral and extraoral appliances, instruments, and miscellaneous products. The company was founded in 1967 and is based in Vista, California.

Open the full interactive analysis →

Similar stocks

Intuitive Surgical, Inc (ISRG) -62% EssilorLuxottica Société anonyme (ESLOF) -44% HOYA Corporation (HOCPY) -42% Medline Inc (MDLN) -15% Becton, Dickinson and Company (BDX) -22% Alcon Inc (ALC) -44%

Frequently asked questions

Is Lancer Orthodontics, Inc (LANZ) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $0.0100 versus a price of $0.0400 — about −75% (overvalued). Model-based estimate, not financial advice.
What is the fair value of LANZ?
Our 21-model fair value for Lancer Orthodontics, Inc is $0.0100 (as of Jun 24, 2026), built from audited fundamentals. The current price is $0.0400.
What is the quality score of LANZ?
Lancer Orthodontics, Inc has a Quality Score of 89/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.